2m 2m 2m 2m 2m 2m 2m
- N/AMarket Cap
- 38.73%1-Year Change
- Financial Data & Stock ExchangesIndustry
Euronext UnSp ADR (ERNXY)
Key Performance
More- Earnings Score: N/A
- Momentum Score: 70
- True Yield: N/A
- Financial Health Score: N/A
Latest Research & News
Euronext announces volumes for July 2026
Euronext announced its trading volumes for July 2026 across its eight European exchanges. The company continues to operate as a leading European capital market infrastructure with over 1,800 listed issuers, €7 trillion in market capitalization, and handles 29% of European lit equity trading.
08/06/2026, 11:45 AM • GlobeNewswire
Half-year statement of the liquidity contract of Euronext NV
Euronext announced the half-year results of its liquidity contract with Rothschild Martin Maurel for the period ending 30 June 2026. The liquidity account holds 3,000 Euronext shares and €19.8 million in cash. Over the period, 8,654 buy transactions and 8,998 sell transactions were executed, trading approximately 981,799 shares bought for €134.3 million and 978,799 shares sold for €133.9 million. Following a reorganization within Rothschild & Co, the liquidity contract management was transferred to Rothschild & Co Global Markets Solutions (Europe) SA effective 1 July 2026, with no impact on contract terms or allocated resources.
07/03/2026, 11:47 AM • GlobeNewswire
Euronext announces volumes for April 2026
Euronext announced its trading volumes for April 2026. The exchange operates across eight European cities and hosts over 1,800 listed issuers with €7 trillion in market capitalization, handling 29% of European lit equity trading.
05/08/2026, 12:00 PM • GlobeNewswire
Euronext announces volumes for February 2026
Euronext announced its trading volumes for February 2026 across its eight regulated exchanges. As of February 2026, the exchange group hosts over 1,800 listed issuers with €7 trillion in market capitalization and handles 29% of European lit equity trading. The announcement includes contact information for investor relations and media inquiries.
03/09/2026, 3:30 AM • GlobeNewswire
Campine NV announces a €7 million investment in third-generation antimony recycling technology, enabling additional annual production of 800-1,000 tons of commercial antimony metal. The company is also transitioning from the fixing market to the continuous market on Euronext Brussels to improve stock liquidity and visibility.
12/18/2025, 3:00 AM • GlobeNewswire
Campine NV is investing €7 million in third-generation antimony recycling technology, enabling production of 800-1,000 tonnes of commercial-grade antimony metal annually. The company is also transitioning from the Euronext Brussels double fixing market to the continuous market to improve share trading accessibility.
12/18/2025, 3:00 AM • GlobeNewswire
NANOBIOTIX va intégrer les indices CAC Mid 60 et SBF 120 d’Euronext Paris
French biotechnology company Nanobiotix has been admitted to the CAC Mid 60 and SBF 120 indices, effective December 19, 2025, which is expected to increase investor visibility and market presence.
12/15/2025, 2:30 AM • GlobeNewswire
Demande de Report de la Tenue de L’assemblée Générale
Auplata Mining Group (AMG) has requested an extension until June 30, 2026, for its annual general meeting due to challenges in finalizing consolidated accounts, including issues with Peruvian accounting certification and pending information from the Moroccan segment.
11/28/2025, 1:06 PM • GlobeNewswire
Correction: Transgene Announces the Temporary Suspension of Trading of its Shares on Euronext Paris
Transgene has requested Euronext Paris to suspend trading of its shares on November 26, 2025, pending publication of capital increase results, with trading expected to resume on November 27, 2025.
11/25/2025, 3:43 PM • GlobeNewswire
Transgene has requested Euronext Paris to suspend trading of its shares starting November 26, 2025, pending the publication of a capital increase result announcement. Trading is expected to resume on November 27, 2025.
11/25/2025, 3:43 PM • GlobeNewswire
Transgene annonce la suspension temporaire de la cotation de ses actions sur Euronext Paris
Transgene has requested a suspension of its stock trading on Euronext Paris starting November 26, 2025, pending the publication of results from its capital increase. Trading is expected to resume on November 28, 2025.
11/25/2025, 2:42 PM • GlobeNewswire
Transgene Announces the Temporary Suspension of Trading of its Shares on Euronext Paris
Transgene, a biotechnology company specializing in immunotherapy for cancer treatment, has requested a trading suspension on Euronext Paris to prepare for a capital increase of approximately 105 million euros.
11/25/2025, 2:42 PM • GlobeNewswire
Euronext submitted a revised voluntary tender offer for ATHEX shares, reducing the minimum number of shares required for completion to 28,925,001 shares (50% plus one share). The Hellenic Capital Market Commission approved the revision on 10 November 2025, with the acceptance period remaining unchanged.
11/10/2025, 12:33 PM • GlobeNewswire
IBA disclosed its current capital structure, total voting rights, and loyalty voting rights as part of legal financial transparency requirements, providing detailed information about its shareholding and voting mechanisms.
11/07/2025, 12:00 PM • GlobeNewswire
Euronext Paris has notified Auplata Mining Group of its unilateral decision to delist the company's securities from Euronext Growth Paris, effective December 31, 2025, citing financial information non-compliance and a previous trading suspension.
10/31/2025, 3:30 PM • GlobeNewswire
Peers
Statistics
MoreInformation as of 10/07/2026
Company Profile
EURONEXT NV UNSP/ADR
Key Executives
- Stéphane Boujnah
- Manuel Bento
- Fabrizio Testa
- Delphine d'Amarzit
- Simon Bartholemew Gallagher
Current Ownership Distribution
- Other2.5B (100.00%)
- Institutions0 (0.00%)
- Mutual Funds0 (0.00%)
- Insiders0 (0.00%)